✦ LIBER ✦

Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy: A PROVE IT-TIMI 22 Substudy

✍ Scribed by Stephen D. Wiviott; Christopher P. Cannon; David A. Morrow; Kausik K. Ray; Marc A. Pfeffer; Eugene Braunwald

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Safety of Aggressive Statin Therapy:

✍ Jacobson, Terry A. 📂 Article 📅 2006 🏛 Mayo Clinic 🌐 English ⚖ 63 KB

Safety and Efficacy of Achieving Very Lo

✍ Stephen D. Wiviott; Satishkumar Mohanavelu; Joel S. Raichlen; Valerie A. Cain; S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 438 KB

Baseline Low-Density Lipoprotein Cholest

✍ Roberto R. Giraldez; Robert P. Giugliano; Satishkumar Mohanavelu; Sabina A. Murp 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Efficacy and safety of ezetimibe co-admi

✍ J. M. CRUZ-Fernández; G. V. Bedarida; J. Adgey; C. Allen; A. O. Johnson-Levonas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Relative Efficacy of Atorvastatin 80 mg

✍ P.M. Ridker; D.A. Morrow; L.M. Rose 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Relative Efficacy of Atorvastatin 80 mg

✍ Paul M. Ridker; David A. Morrow; Lynda M. Rose; Nader Rifai; Christopher P. Cann 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 102 KB